Compound 477
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1nnc2CCCN(CCn12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C44H52ClF3N8O4S3/c1-53(2)24-20-35(31-61-37-10-4-3-5-11-37)49-40-19-18-38(29-41(40)62(57,58)44(46,47)48)63(59,60)52-43-51-50-42-13-8-23-55(27-28-56(42)43)36-21-25-54(26-22-36)30-33-9-6-7-12-39(33)32-14-16-34(45)17-15-32/h3-7,9-12,14-19,29,35-36,49H,8,13,20-28,30-31H2,1-2H3,(H,51,52)/t35-/m1/s1
- InChiKey:
AUTRVIRCWHUZPC-PGUFJCEWSA-N
External links
168318181 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 93 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.62 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 944.29 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.13 | |||
TPSA | 132.77 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 93 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.62 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4857 | Navitoclax | DB12340 | |
0.3587 | Lenacapavir | DB15673 | |
0.3489 | Anatibant | DB05038 | |
0.3460 | Presatovir | DB12165 | |
0.3445 | CE-326597 | DB12694 | |
0.3425 | Elobixibat | DB12486 | |
0.3400 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3377 | GSK-1292263 | DB12627 | |
0.3342 | Birabresib | DB15189 | |
0.3333 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3333 | Etoperidone | DB09194 | |
0.3333 | Pipotiazine | DB01621 | |
0.3324 | Venetoclax | DB11581 | |
0.3309 | ASP-3026 | DB12729 | |
0.3309 | Lorpiprazole | DB09195 |